Ramja Genosensor

Prathamasense: Diagnostic Device for Microbial Infection and Antimicrobial Resistance



Kits and 20 devices to be deployed in healthcare facilities


blood and urine samples to be examined

Geographical Focus
  • Pan India

Samridh support

SAMRIDH is providing financial assistance to Ramja Genosensor to scale the production and distribution capacity of the PRATHMASENSE device and kit, conduct crucial clinical trials in hospitals, and administer research and development for product upgradation. The collaboration aims to deploy 50 kits and 20 devices at health facilities across India, with a focus on tier II and III cities. Additionally, the support aims to strengthen marketing and sales plans for the solution, targeting both B2B (business-to-business) and B2G (business-to-government) markets through distributor partnerships, informative webinars, and influencer marketing. This multi-pronged approach ensures widespread access and adoption of this potentially life-saving technology.

1.2 Million people died from antibiotic-resistant bacterial infections in 2019, globally.[1]

10 Million people are estimated to lose their lives by 2050, due to antimicrobial resistance (AMR).[2]

24 Million people can be pushed into extreme poverty by 2030, due to AMR.[3]

Globally, Antimicrobial Resistance (AMR) poses a significant challenge in healthcare, impacting treatment effectiveness and straining healthcare systems. Timely infection detection, especially in ICUs, is vital. However, traditional diagnostic methods like cultures are slow, taking 2-5 days for results, leading to delayed antibiotic prescription. Despite guidelines advocating for 100% baseline culture investigation in ICUs, immediate results are unavailable, exacerbating AMR. Overuse and misuse of antibiotics contribute to drug-resistant infections, emphasizing the critical need for swift diagnosis to prevent further escalation of AMR-related challenges and safeguard patient well-being.

Ramja Genosensor’s PRATHMASENSE is a rapid, user-friendly, and cost-efficient solution for detecting microbial infections and antimicrobial susceptibility/resistance in less than 2 hours. Utilizing an electrochemical DNA biosensor, this innovative device identifies gene-specific bacteria via a redox reaction on the screen-printed electrode. Through microfabrication-based technology, this genotypic test swiftly detects infection-causing bacteria and superbug resistance, capable of isolating genomic DNA from diverse samples, including 1 ml of blood, urine, or any biological fluid. Ramja Genosensor aims to reduce deaths from delayed diagnosis, minimize healthcare costs, and improve patient outcomes.